9/15/2017
AUDUBON, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it completed its first orthopedic trauma surgical case. Globus Medical’s new ANTHEM™ Distal Radius Fracture System was used by Dr. Asif Ilyas, Hand Surgeon and Trauma Surgeon with The Rothman Institute at Thomas Jefferson University in Philadelphia PA, to successfully treat a distal radius fracture.
The ANTHEM™ Distal Radius Fracture System is a comprehensive fixation system designed to treat a variety of traumatic wrist fractures with anatomically contoured plates for intraoperative versatility. “This is the first orthopedic trauma surgery performed using a plating system designed, manufactured and sold by Globus Medical,” said Barclay Davis, Vice President, Orthopedic Trauma. “We are very proud to continue Globus’ reputation for innovation, speed to market, and listening to our surgeon customers, by bringing this philosophy to the orthopedic trauma market. This introduction is the culmination of a significant effort between Globus Medical’s outstanding product development team and leading orthopedic trauma surgeons. And there are many more to come.” 
The innovative ANTHEM™ plate design allows a clear view of the fracture line for improved diagnosis and care. “This plate features a positioning slot and screw that allows multidirectional fine tuning of plate position to provide surgeons maximum flexibility during surgery. I am impressed by how intuitive the tray and system are and how natural the instrumentation feels. The implant was seamless in its placement and fixation,” said Dr. Asif Ilyas. “Trauma is a large, busy, and complex space. That space is ready for a company like Globus to take our current designs and technology and advance them to the next level.”
Globus Medical is planning to introduce its new orthopedic trauma product line at the Orthopaedic Trauma Association’s 33rd Annual Meeting to be held October 11-14, 2017 in Vancouver, Canada.
Indications
The ANTHEM™ Fracture System is indicated for fixation of fractures, osteotomies, arthrodesis and reconstruction of bones for the appropriate size of the device to be used in adult patients, including the clavicle, scapula, humerus, radius, ulna, small bones (metacarpals, metatarsals, phalanges), wrist, pelvis, femur, tibia, fibula, ankle, and foot. Small fragment and distal fibula plates may be used in all pediatric subgroups (except neonates) and small stature adults. Distal radius plates may be used in adolescents (12-21 years of age).
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to successfully integrate the international operations acquired from Alphatec, both in general and on our anticipated timeline, our ability to transition Alphatec’s international customers to Globus Medical products, our ability to realize the expected benefits to our results from the Alphatec acquisition, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contact :
Daniel Scavilla
Senior Vice President, Chief Financial Officer
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com